Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 342

Similar articles for PubMed (Select 16306347)

1.

Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.

Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL.

Diabetes. 2005 Dec;54 Suppl 2:S97-107. Review.

2.

Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms.

Brozzi F, Nardelli TR, Lopes M, Millard I, Barthson J, Igoillo-Esteve M, Grieco FA, Villate O, Oliveira JM, Casimir M, Bugliani M, Engin F, Hotamisligil GS, Marchetti P, Eizirik DL.

Diabetologia. 2015 Jun 23. [Epub ahead of print]

PMID:
26099855
3.
4.

CHOP links endoplasmic reticulum stress to NF-κB activation in the pathogenesis of nonalcoholic steatohepatitis.

Willy JA, Young SK, Stevens JL, Masuoka HC, Wek RC.

Mol Biol Cell. 2015 Jun 15;26(12):2190-204. doi: 10.1091/mbc.E15-01-0036. Epub 2015 Apr 22.

PMID:
25904325
5.

Is nitric oxide really the primary mediator of pancreatic β-cell death in type 1 diabetes?

Gurgul-Convey E, Lenzen S.

J Biol Chem. 2015 Apr 17;290(16):10570. doi: 10.1074/jbc.L115.648089. No abstract available.

PMID:
25888569
6.

CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.

Burke SJ, Karlstad MD, Regal KM, Sparer TE, Lu D, Elks CM, Grant RW, Stephens JM, Burk DH, Collier JJ.

Biochim Biophys Acta. 2015 Jun;1849(6):637-52. doi: 10.1016/j.bbagrm.2015.03.007. Epub 2015 Apr 13.

PMID:
25882704
7.

Role of pro-inflammatory cytokines of pancreatic islets and prospects of elaboration of new methods for the diabetes treatment.

Cieślak M, Wojtczak A, Cieślak M.

Acta Biochim Pol. 2015;62(1):15-21. Epub 2015 Mar 18.

8.
9.

[Obesity and diabetes mellitus].

Tron'ko ND, Zak KP.

Lik Sprava. 2013 Dec;(8):3-21. Review. Russian.

PMID:
25726672
10.
11.

Pancreatic cancer-associated diabetes is an "exosomopathy".

Korc M.

Clin Cancer Res. 2015 Apr 1;21(7):1508-10. doi: 10.1158/1078-0432.CCR-14-2990. Epub 2015 Feb 2.

PMID:
25645860
12.

Decrease in ATP biosynthesis and dysfunction of biological membranes. Two possible key mechanisms of phenoptosis.

Rzheshevsky AV.

Biochemistry (Mosc). 2014 Oct;79(10):1056-68. doi: 10.1134/S0006297914100071.

13.

Selective and sequential loss of transcriptional factors: A hallmark of β-cell failure in type 2 diabetes?

Shirakawa J, Terauchi Y.

J Diabetes Investig. 2014 Jul;5(4):359-61. doi: 10.1111/jdi.12212. Epub 2014 Mar 28. No abstract available.

14.

Activation of the NLRP3 inflammasome complex is not required for stress-induced death of pancreatic islets.

Wali JA, Gurzov EN, Fynch S, Elkerbout L, Kay TW, Masters SL, Thomas HE.

PLoS One. 2014 Nov 18;9(11):e113128. doi: 10.1371/journal.pone.0113128. eCollection 2014.

15.

Current research on cell death mechanisms.

Bolt HM, Ahmed H, Hammad S.

Arch Toxicol. 2014 Dec;88(12):2079-82. doi: 10.1007/s00204-014-1411-7. No abstract available.

PMID:
25395008
16.

Apoptosis of beta cells in diabetes mellitus.

Anuradha R, Saraswati M, Kumar KG, Rani SH.

DNA Cell Biol. 2014 Nov;33(11):743-8. doi: 10.1089/dna.2014.2352. Epub 2014 Aug 5. Review.

PMID:
25093391
17.

Interferon stimulated gene 15 has an anti-apoptotic effect on MIN6 cells.

Yoshikawa A, Imagawa A, Nakata S, Fukui K, Kuroda Y, Miyata Y, Sato Y, Hanafusa T, Matsuoka TA, Kaneto H, Iwahashi H, Shimomura I.

Endocr J. 2014;61(9):883-90. Epub 2014 Jul 15.

18.

Evidence of contribution of iPLA2β-mediated events during islet β-cell apoptosis due to proinflammatory cytokines suggests a role for iPLA2β in T1D development.

Lei X, Bone RN, Ali T, Zhang S, Bohrer A, Tse HM, Bidasee KR, Ramanadham S.

Endocrinology. 2014 Sep;155(9):3352-64. doi: 10.1210/en.2013-2134. Epub 2014 Jul 8.

PMID:
25004092
19.

[Chronicle of a death foretold: endoplasmic reticulum stress and beta cell apoptosis in diabetes].

Eizirik DL, Millard I.

Med Sci (Paris). 2014 May;30(5):496-9. doi: 10.1051/medsci/20143005007. Epub 2014 Jun 13. French. No abstract available.

20.

Effects of IL-1β-Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying Mechanisms.

Palmér R, Nyman E, Penney M, Marley A, Cedersund G, Agoram B.

CPT Pharmacometrics Syst Pharmacol. 2014 Jun 11;3:e118. doi: 10.1038/psp.2014.16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk